Intensity Therapeutics Inc (INTS)

Currency in USD
0.283
+0.031(+12.10%)
Real-time Data·
INTS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
INTS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2600.300
52 wk Range
0.1854.700
Key Statistics
Prev. Close
0.252
Open
0.27
Day's Range
0.26-0.3
52 wk Range
0.185-4.7
Volume
4.52M
Average Volume (3m)
3.47M
1-Year Change
-94.68%
Book Value / Share
0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INTS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.400
Upside
+1,101.41%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Intensity Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Intensity Therapeutics Inc Company Profile

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Compare INTS to Peers and Sector

Metrics to compare
INTS
Peers
Sector
Relationship
P/E Ratio
−0.4x−4.6x−0.5x
PEG Ratio
−0.020.010.00
Price/Book
18.9x2.7x2.6x
Price / LTM Sales
-151.9x3.3x
Upside (Analyst Target)
-188.7%43.4%
Fair Value Upside
Unlock4.9%7.1%Unlock

Analyst Ratings

4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.400
(+1,101.41% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.13 / -0.16
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

INTS Income Statement

People Also Watch

18.13
SRPT
+0.92%
0.0453
WLGS
+7.86%
0.04
GIBO
-2.83%
0.552
WINT
-5.93%
1.79
RBNE
+2.91%

FAQ

What Stock Exchange Does Intensity Therapeutics Trade On?

Intensity Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Intensity Therapeutics?

The stock symbol for Intensity Therapeutics is "INTS."

What Is the Intensity Therapeutics Market Cap?

As of today, Intensity Therapeutics market cap is 6.32M.

What Is Intensity Therapeutics's Earnings Per Share (TTM)?

The Intensity Therapeutics EPS (TTM) is -1.05.

When Is the Next Intensity Therapeutics Earnings Date?

Intensity Therapeutics will release its next earnings report on 17 Nov 2025.

From a Technical Analysis Perspective, Is INTS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Intensity Therapeutics Stock Split?

Intensity Therapeutics has split 1 times.

How Many Employees Does Intensity Therapeutics Have?

Intensity Therapeutics has 6 employees.

What is the current trading status of Intensity Therapeutics (INTS)?

As of 08 Aug 2025, Intensity Therapeutics (INTS) is trading at a price of 0.28, with a previous close of 0.25. The stock has fluctuated within a day range of 0.26 to 0.30, while its 52-week range spans from 0.19 to 4.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.